BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 10918444)

  • 61. Participation of MicroRNAs in the Treatment of Cancer with Phytochemicals.
    Son SW; Lee HY; Moeng S; Kuh HJ; Choi SY; Park JK
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33066509
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The Emerging Role of Cyclin-Dependent Kinases (CDKs) in Pancreatic Ductal Adenocarcinoma.
    GarcĂ­a-Reyes B; Kretz AL; Ruff JP; von Karstedt S; Hillenbrand A; Knippschild U; Henne-Bruns D; Lemke J
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30340359
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Caspase-3 promotes genetic instability and carcinogenesis.
    Liu X; He Y; Li F; Huang Q; Kato TA; Hall RP; Li CY
    Mol Cell; 2015 Apr; 58(2):284-96. PubMed ID: 25866249
    [TBL] [Abstract][Full Text] [Related]  

  • 64. SATB1 collaborates with loss of p16 in cellular transformation.
    Agrelo R; Kishimoto H; Novatchkova M; Peraza V; Paolino M; Souabni A; Wutz A
    Oncogene; 2013 Nov; 32(48):5492-500. PubMed ID: 23686316
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Transduction of E2F-1 TAT fusion proteins represses expression of hTERT in primary ductal breast carcinoma cell lines.
    Elliott KA; Rickords LF; Labrum JM
    Mol Cancer; 2008 Mar; 7():28. PubMed ID: 18366791
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The expression of cyclin-dependent kinase inhibitors p15, p16, p21, and p27 during ovarian follicle growth initiation in the mouse.
    Bayrak A; Oktay K
    Reprod Biol Endocrinol; 2003 May; 1():41. PubMed ID: 12777178
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The INK4A/ARF locus: role in cell cycle control and apoptosis and implications for glioma growth.
    Ivanchuk SM; Mondal S; Dirks PB; Rutka JT
    J Neurooncol; 2001 Feb; 51(3):219-29. PubMed ID: 11407594
    [TBL] [Abstract][Full Text] [Related]  

  • 68. p16INK4a: a gene with a dual capacity to encode unrelated proteins that inhibit cell cycle progression.
    Larsen CJ
    Oncogene; 1996 May; 12(10):2041-4. PubMed ID: 8668328
    [No Abstract]   [Full Text] [Related]  

  • 69. Effects of adenovirus-mediated p16INK4A expression on cell cycle arrest are determined by endogenous p16 and Rb status in human cancer cells.
    Craig C; Kim M; Ohri E; Wersto R; Katayose D; Li Z; Choi YH; Mudahar B; Srivastava S; Seth P; Cowan K
    Oncogene; 1998 Jan; 16(2):265-72. PubMed ID: 9464545
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Adenovirus-mediated p16INK4a gene expression radiosensitizes non-small cell lung cancer cells in a p53-dependent manner.
    Kawabe S; Roth JA; Wilson DR; Meyn RE
    Oncogene; 2000 Nov; 19(47):5359-66. PubMed ID: 11103937
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Promoting apoptosis: a novel activity associated with the cyclin-dependent kinase inhibitor p27.
    Katayose Y; Kim M; Rakkar AN; Li Z; Cowan KH; Seth P
    Cancer Res; 1997 Dec; 57(24):5441-5. PubMed ID: 9407946
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Silibinin causes cell cycle arrest and apoptosis in human bladder transitional cell carcinoma cells by regulating CDKI-CDK-cyclin cascade, and caspase 3 and PARP cleavages.
    Tyagi A; Agarwal C; Harrison G; Glode LM; Agarwal R
    Carcinogenesis; 2004 Sep; 25(9):1711-20. PubMed ID: 15117815
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The inhibitory effect of adenovirus-mediated p16INK4a gene transfer on the proliferation of lung cancer cell line.
    Lee JH; Lee CT; Yoo CG; Hong YK; Kim CM; Han SK; Shim YS; Carbone DP; Kim YW
    Anticancer Res; 1998; 18(5A):3257-61. PubMed ID: 9858892
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Induction of apoptosis in p16INK4A mutant cell lines by adenovirus-mediated overexpression of p16INK4A protein.
    Kim M; Katayose Y; Rojanala L; Shah S; Sgagias M; Jang L; Jung YJ; Lee SH; Hwang SG; Cowan KH
    Cell Death Differ; 2000 Aug; 7(8):706-11. PubMed ID: 10918444
    [TBL] [Abstract][Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.